Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 108

    1.

    Clinical and biochemical heterogeneity of depressive disorders.

    Maas JW.

    Ann Intern Med. 1978 Apr;88(4):556-63. Review.PMID: 25035 [PubMed - indexed for MEDLINE]Related articles

    2.

    Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression.

    Maas JW.

    Arch Gen Psychiatry. 1975 Nov;32(11):1357-61.PMID: 1200759 [PubMed - indexed for MEDLINE]Related articles

    3.

    MHPG excretion by patients with affective disorders.

    Maas JW, Dekirmenjian H, Fawcett JA.

    Int Pharmacopsychiatry. 1974;9(1):14-26. Review. No abstract available. PMID: 4600126 [PubMed - indexed for MEDLINE]Related articles

    4.

    Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.

    Schildkraut JJ.

    Am J Psychiatry. 1973 Jun;130(6):695-9. No abstract available. PMID: 4701961 [PubMed - indexed for MEDLINE]Related articles

    5.

    Catecholamine metabolism, depressive illness, and drug response.

    Maas JW, Fawcett JA, Dekirmenjian H.

    Arch Gen Psychiatry. 1972 Mar;26(3):252-62. No abstract available. PMID: 4551050 [PubMed - indexed for MEDLINE]Related articles

    6.

    Affective disorders and norepinephrine pharmacology.

    Schildkraut JJ, Schanberg SM, Kopin IJ, Durell J.

    Int Psychiatry Clin. 1969;6(2):83-141. No abstract available. PMID: 4897536 [PubMed - indexed for MEDLINE]Related articles

    7.

    Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients.

    Linnoila M, Karoum F, Calil HM, Kopin IJ, Potter WZ.

    Arch Gen Psychiatry. 1982 Sep;39(9):1025-8.PMID: 6214234 [PubMed - indexed for MEDLINE]Related articles

    8.

    Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites.

    Schildkraut JJ, Orsulak PJ, LaBrie RA, Schatzberg AF, Gudeman JE, Cole JO, Rohde WA.

    Arch Gen Psychiatry. 1978 Dec;35(12):1436-9.PMID: 727879 [PubMed - indexed for MEDLINE]Related articles

    9.

    Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.

    Schildkraut JJ, Orsulak PJ, Schatzberg AF, Gudeman JE, Cole JO, Rohde WA, LaBrie RA.

    Arch Gen Psychiatry. 1978 Dec;35(12):1427-33.PMID: 727878 [PubMed - indexed for MEDLINE]Related articles

    10.

    Catecholamine metabolism in affective disorders. IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline.

    Schildkraut JJ, Draskoczy PR, Gershon ES, Reich P, Grab EL.

    J Psychiatr Res. 1972 Sep;9(3):173-85. No abstract available. PMID: 5083173 [PubMed - indexed for MEDLINE]Related articles

    11.

    Catecholamine measures for diagnosis and treatment of patients with depressive disorders.

    Schatzberg AF, Orsulak PJ, Rosenbaum AH, Kruger ER, Schildkraut JJ, Cole JO.

    J Clin Psychiatry. 1980 Dec;41(12 Pt 2):35-9.PMID: 7440524 [PubMed - indexed for MEDLINE]Related articles

    12.

    Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients.

    Katz MM, Maas JW, Frazer A, Koslow SH, Bowden CL, Berman N, Swann AC, Stokes PE.

    Neuropsychopharmacology. 1994 Oct;11(2):89-100.PMID: 7530963 [PubMed - indexed for MEDLINE]Related articles

    13.

    The neuropharmacology of depression.

    Adolphe AB, Dorsey ER, Napoliello MJ.

    Dis Nerv Syst. 1977 Oct;38(10):841-6. No abstract available. PMID: 20285 [PubMed - indexed for MEDLINE]Related articles

    14.

    Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs.

    Maas JW, Koslow SH, Katz MM, Bowden CL, Gibbons RL, Stokes PE, Robins E, Davis JM.

    Am J Psychiatry. 1984 Oct;141(10):1159-71.PMID: 6207736 [PubMed - indexed for MEDLINE]Related articles

    15.

    Biochemical criteria for classifying depressive disorders and predicting responses to pharmacotherapy: preliminary findings from studies of norepinephrine metabolism. Contributions to biochemistry.

    Schildkraut JJ.

    Pharmakopsychiatr Neuropsychopharmakol. 1974 Mar;7(2):98-107. No abstract available. PMID: 4438430 [PubMed - indexed for MEDLINE]Related articles

    16.

    Biochemistry and treatment strategies for depression.

    Garvey MJ.

    J Fam Pract. 1980 Aug;11(2):215-9.PMID: 6106040 [PubMed - indexed for MEDLINE]Related articles

    17.

    Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action.

    Schildkraut JJ, Schanberg SM, Breese GR, Kopin IJ.

    Am J Psychiatry. 1967 Nov;124(5):600-8. No abstract available. PMID: 4383104 [PubMed - indexed for MEDLINE]Related articles

    18.

    Biogenic amines and depression. The potential value of biochemical parameters in the diagnosis and medication of affective disorders.

    Ridges AP.

    Postgrad Med J. 1976;52(3 suppl):9-17. Review. No abstract available. PMID: 785425 [PubMed - indexed for MEDLINE]Related articles

    19.

    Stimulant drug treatment of hyperactivity: biochemical correlates.

    Elia J, Borcherding BG, Potter WZ, Mefford IN, Rapoport JL, Keysor CS.

    Clin Pharmacol Ther. 1990 Jul;48(1):57-66.PMID: 2196146 [PubMed - indexed for MEDLINE]Related articles

    20.

    Common mechanism of action of biochemically "specific" antidepressants.

    Potter WZ, Karoum F, Linnoila M.

    Prog Neuropsychopharmacol Biol Psychiatry. 1984;8(1):153-61.PMID: 6233636 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data